A comparative study of milnacipran and paroxetine in outpatients with major depression

Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study

Journal of Affective Disorders · 1990 · 399 citations

Medicine, Pharmacology, Pharmacotherapy +17

Citalopram: Clinical effect profile in comparison with clomipramine. A controlled multicenter study

LarsF. Gram · Psychopharmacology · 1986 · 303 citations

Medicine, Pharmacology, Pharmacotherapy +10

A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia

G. Clerc, P. Ruimy, J. Verdeau‐Paillés · International Clinical Psychopharmacology · 1994 · 300 citations

Medicine, Pharmacotherapy, Psychiatry +16

The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants

Ian Anderson, Barbara Tomenson · Journal of Psychopharmacology · 1994 · 250 citations

Pharmacy, Pharmacotherapy, Psychiatry +16

Biochemical profile of midalcipran (F 2207), 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug

Chantal Moret, Marie Charvéron, J. P. M. Finberg et al. · Neuropharmacology · 1985 · 173 citations

Medicine, Medicinal Chemistry, Pharmacology +14